Literature DB >> 3653981

Immunosuppressive effects of Centipeda periodontii: selective cytotoxicity for lymphocytes and monocytes.

B J Shenker1, P Berthold, P Dougherty, K K Porter.   

Abstract

We have examined soluble sonic extracts prepared from several strains of Centipeda periodontii for their ability to alter human lymphocyte function. These organisms were isolated from subgingival plaque of patients with periodontal disease. We found that sonicates from several, but not all, strains of C. periodontii caused a dose-dependent inhibition of lymphocyte responsiveness to concanavalin A, phytohemagglutinin, pokeweed mitogen, and formalinized Staphylococcus aureus. Inhibition was associated with a concomitant decrease in cell viability assessed by trypan blue exclusion, 51Cr release, and electron microscopy. The maximal number of dead cells was observed 20 to 24 h after exposure to the sonic extract. Susceptible cells include human lymphocytes (both B and T), monocytes, and erythrocytes, whereas polymorphonuclear cells, murine L-929 fibroblasts, and sheep erythrocytes were not affected. Preliminary characterization of the cytotoxic activity indicates that it is heat labile and trypsin sensitive and has an Mr of 60,000. It has been proposed that impaired host defense may play a pivotal role in the pathogenesis of periodontal diseases. The data presented in this paper suggest that immunosuppression (local or systemic or both) could be initiated by C. periodontii. This immunosuppression may alter the nature and consequences of host-parasite interactions, thereby enhancing the pathogenicity of C. periodontii itself or some other opportunistic organism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653981      PMCID: PMC260709          DOI: 10.1128/iai.55.10.2332-2340.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease.

Authors:  L Ivanyi; T Lehner
Journal:  Arch Oral Biol       Date:  1970-11       Impact factor: 2.633

2.  Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans.

Authors:  B J Shenker; M E Kushner; C C Tsai
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

3.  Enzymatic and antigenic characterization of immunoglobulin A1 proteases from Bacteroides and Capnocytophaga spp.

Authors:  E V Frandsen; J Reinholdt; M Kilian
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella.

Authors:  P Arneborn; G Biberfeld
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Inhibition of mitogen-induced proliferation of mouse T and B lymphocytes by bloodstream forms of Trypanosoma cruzi.

Authors:  J R Maleckar; F Kierszenbaum
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Alveolar bone loss in rats after immunization with Actinomyces viscosus.

Authors:  J J Burckhardt; R Gaegauf-Zollinger; R Schmid; B Guggenheim
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  Leukotoxicity of an extract from Actinobacillus actinomycetemcomitans for human gingival polymorphonuclear leukocytes.

Authors:  N S Taichman; J M Wilton
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

9.  Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).

Authors:  K Kato; K Yamamoto; T Kimura; I Azuma; P W Askenase
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  5 in total

1.  Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  G Rabie; E T Lally; B J Shenker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

Authors:  B J Shenker; L A Vitale; D A Welham
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

3.  Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.

Authors:  B J Shenker; L Vitale; J Slots
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Immune suppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells.

Authors:  U Knipp; S Birkholz; W Kaup; W Opferkuch
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

5.  Centipeda periodontii in human periodontitis.

Authors:  Thomas E Rams; Charles E Hawley; Eugene J Whitaker; John E Degener; Arie J van Winkelhoff
Journal:  Odontology       Date:  2014-07-19       Impact factor: 2.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.